Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Molecularly Determined Treatment of Diffuse Intrinsic Pontine Gliomas (DIPG)

This study is ongoing, but not recruiting participants.
Boston Children’s Hospital
University of California, San Francisco
Ann & Robert H Lurie Children's Hospital of Chicago
Children's Healthcare of Atlanta
Children's Hospital Colorado
Children's Hospital Los Angeles
Children's Hospital of Michigan
Children's Hospitals and Clinics of Minnesota
Cook Children's Medical Center
Doernbecher Children's Hospital
Duke University
Johns Hopkins University
Nicklaus Children's Hospital f/k/a Miami Children's Hospital
Nemours Children's Clinic Jacksonville
New York University
Milton S. Hershey Medical Center
Seattle Children's
Lucile Packard Children's Hospital
University of Louisville
UT Southwestern Medical Center
Washington University School of Medicine
Phoenix Children's Hospital
Medical University of South Carolina
Information provided by (Responsible Party):
Mark W. Kieran, MD, PhD, Dana-Farber Cancer Institute Identifier:
First received: August 12, 2010
Last updated: October 17, 2015
Last verified: October 2015
No Study Results Posted on for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: March 2017 (Final data collection date for primary outcome measure)